{reportSlug=global-irritable-bowel-syndrome-treatment-market, reportId=56610, mktKeyword=Irritable Bowel Syndrome Treatment, cagr=0.00, publishDate=Jan 2024, priceOption2=6500, reportTitle=Irritable Bowel Syndrome Treatment Comprehensive Study by Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Ramosetron Hydrochloride, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Medical Condition (IBS-constipation, IBS-diarrhea) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=200, priceOption1=3450, forecastYr=2027, noOfPages=215, reportKey=56304, breadcrum=Global Irritable Bowel Syndrome Treatment}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Jan 2024
215 Pages
68 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries